Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by Quanadienon Jul 29, 2021 9:18am
131 Views
Post# 33620173

RE:RE:RE:RE:RE:RE:RE:RE:looks like we have nice upsite today

RE:RE:RE:RE:RE:RE:RE:RE:looks like we have nice upsite today
woundedknee wrote: Do the doctors, as individuals, have the discretion to buy on their own? I would say no. This needs to be sold to hospital administrations and larger institutions like the collaboration we now have with GE. On the other hand, you're right, in the sense that doctors are the users and can alert those with the power and purse strings.


Yeah Im pretty sure a doctor cant buy it for himself... must probably need to be approved by administration... also I would say even the administration of the hospital... probably must need to know if insurance would pay for that kind of service. They do pay for MRI as it is known and consider valid. But would they pay for that new kind of service... I think is also to be determined. If insurance companies dont reimburse what VPT technologies gives as information... I doubt management will buy their product as they wont be able to bill for that service. Also... it wouldnt be great news if the sales are mostly individual like (1-2 units per transaction....) I think investors are hoping for a significant number of units sold per transaction (a number I do not know... as we dont even know they sell one for how much.... or maybe you guys got a number $ for a unit??) Glta
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse